Eastman Chemical Co (EMN) stock
Close on Nov 17, 2026Market cap $7.13BP/E 11.5Yield 5.35%
Earnings
Eastman Chemical's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Eastman Chemical's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Jan 28, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 29, 2026after the close | $2.39B | +8.3% | $2.19 | $1.84 | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 30, 2026after the close | $2.51B | +9.9% | $1.59 | $1.97 | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 30, 2026after the close | $2.18B | -4.9% | $0.93 | $1.09 | Release |
| Q4 FY2025ended Dec 31, 2025 | Jan 29, 2026after the close | $1.97B | -12.1% | $0.92 | $0.75 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 3, 2025after the close | $2.20B | – | $0.40 | $1.14 | Release |
| Q2 FY2025ended Jun 30, 2025 | Jul 31, 2025after the close | $2.29B | -3.2% | $1.20 | $1.60 | Release |
| Q1 FY2025ended Mar 31, 2025 | Apr 24, 2025after the close | $2.29B | -0.9% | $1.57 | $1.91 | Release |
| Q4 FY2024ended Dec 31, 2024 | Jan 30, 2025after the close | $2.25B | +1.7% | $2.82 | $1.87 | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 31, 2024after the close | – | – | – | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Jul 25, 2024after the close | $2.36B | +1.7% | $1.94 | $2.15 | Release |
| Q1 FY2024ended Mar 31, 2024 | Apr 25, 2024after the close | $2.31B | -4.2% | $1.39 | $1.61 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 1, 2024after the close | $2.21B | -7.0% | $2.61 | $1.31 | Release |
| Q3 FY2023ended Sep 30, 2023 | Oct 26, 2023after the close | $2.27B | -16.3% | $1.49 | $1.47 | Release |
| Q2 FY2023ended Jun 30, 2023 | Jul 27, 2023after the close | $2.32B | -16.5% | $2.27 | $1.99 | Release |
| Q1 FY2023ended Mar 31, 2023 | Apr 27, 2023after the close | $2.41B | -11.1% | $1.12 | $1.63 | Release |
| Q4 FY2022ended Dec 31, 2022 | Jan 26, 2023after the close | $2.37B | -11.9% | $0.01 | $0.89 | Release |
| Q3 FY2022ended Sep 30, 2022 | Oct 27, 2022after the close | $2.71B | -0.4% | $2.46 | $2.05 | Release |
| Q2 FY2022ended Jun 30, 2022 | Jul 28, 2022after the close | $2.78B | – | $2.03 | $2.83 | Release |
| Q1 FY2022ended Mar 31, 2022 | Apr 28, 2022after the close | $2.71B | – | $1.80 | $2.06 | Release |
| Q4 FY2021ended Dec 31, 2021 | Jan 27, 2022after the close | $2.69B | – | $2.81 | $1.81 | Release |
| Q3 FY2021ended Sep 30, 2021 | Oct 28, 2021after the close | $2.72B | – | $2.57 | $2.46 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 2, 2021after the close | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | Apr 29, 2021after the close | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Jan 28, 2021after the close | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Oct 29, 2020after the close | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Eastman Chemical's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| adjusted earnings per sharenon-GAAP | FY2026 | $6.00 – $6.20 | – | New | Oct 29, 2026 |
| capital expenditures | FY2026 | $400.00M | $400.00M | Reaffirmed | Jul 30, 2026 |
| cost savings, net of inflation | FY2026 | $125.00M – $150.00M | – | New | Jul 30, 2026 |
| cost structure reduction actionsnon-GAAP | FY2026 | $125.00M – $150.00M | – | New | Jan 29, 2026 |
| operating cash flow | FY2026 | $850.00M | – | New | Oct 29, 2026 |
| operating cash flow | FY2026 | $900.00M | – | Raised | Jul 30, 2026 |
Guidance vs results
The last range Eastman Chemical gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q3 FY2026 | third-quarter adjusted EPS | $1.97 | $1.84 | Below range |
| Q2 FY2026 | adjusted EPS | $1.70 – $1.90 | $1.97 | Above range |
| Q1 FY2026 | adjusted EPS | $1.00 – $1.20 | $1.09 | Within range |
| FY2025 | adjusted earnings per share | $5.40 – $5.65 | $5.40Σ4Q | Within range |
| Q3 FY2025 | adjusted earnings per share | $1.25 | $1.14 | Below range |
| Q2 FY2025 | adjusted EPS | $1.70 – $1.90 | $1.60 | Below range |
| Q4 FY2022 | adjusted EPS | $1.10 – $1.40 | $0.89 | Below range |
Guidance history
Every forecast Eastman Chemical put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 29, 2026 | adjusted earnings per share | FY2026 | $6.00 – $6.20 | New |
| Oct 29, 2026 | operating cash flow | FY2026 | $850.00M | New |
| Jul 30, 2026 | capital expenditures | FY2026 | $400.00M | Reaffirmed |
| Jul 30, 2026 | third-quarter adjusted EPS | Q3 FY2026 | $1.97 | New |
| Jul 30, 2026 | cost savings, net of inflation | FY2026 | $125.00M – $150.00M | New |
| Jul 30, 2026 | operating cash flow | FY2026 | $900.00M | Raised |
| Apr 30, 2026 | capital expenditures | FY2026 | $400.00M | New |
| Apr 30, 2026 | adjusted EPS | Q2 FY2026 | $1.70 – $1.90 | New |
| Jan 29, 2026 | adjusted EPS | Q1 FY2026 | $1.00 – $1.20 | New |
| Jan 29, 2026 | cost structure reduction actions | FY2026 | $125.00M – $150.00M | New |
| Nov 3, 2025 | adjusted earnings per share | FY2025 | $5.40 – $5.65 | New |
| Nov 3, 2025 | operating cash flow | FY2025 | $1.00B | New |
| Jul 31, 2025 | adjusted earnings per share | Q3 FY2025 | $1.25 | New |
| Jul 31, 2025 | operating cash flow | FY2025 | $1.00B | Lowered |
| Apr 24, 2025 | capital expenditures | FY2025 | $550.00M | New |
| Apr 24, 2025 | adjusted EPS | Q2 FY2025 | $1.70 – $1.90 | New |
| Apr 24, 2025 | cost reduction target | FY2025 | $75.00M | Lowered |
| Apr 24, 2025 | operating cash flow | FY2025 | $1.20B | Raised |
| Jan 30, 2025 | EBITDA growth | FY2025 | $75.00M – $100.00M | New |
| Jan 30, 2025 | EPS | FY2025 | $8.00 – $8.75 | New |
| Jan 30, 2025 | cash from operations | FY2025 | $1.30B | New |
| Oct 31, 2024 | EPS | FY2024 | $7.50 – $7.70 | Narrowed |
| Oct 31, 2024 | cash from operations | FY2024 | $1.30B | Lowered |
| Jul 25, 2024 | incremental EBITDA contribution | FY2024 | $50.00M | New |
| Jul 25, 2024 | EPS | FY2024 | $7.40 – $7.85 | Narrowed |
| Jul 25, 2024 | cash from operations | FY2024 | $1.40B | Reaffirmed |
| Apr 25, 2024 | EPS | FY2024 | $7.25 – $8.00 | Reaffirmed |
| Apr 25, 2024 | cash from operations | FY2024 | $1.40B | Reaffirmed |
| Feb 1, 2024 | EPS | FY2024 | $7.25 – $8.00 | New |
| Feb 1, 2024 | cash from operations | FY2024 | $1.40B | New |
| Oct 26, 2023 | EPS | FY2023 | $6.30 – $6.50 | Lowered |
| Oct 26, 2023 | operating cash flow | FY2023 | $1.40B | Reaffirmed |
| Jul 27, 2023 | EPS | FY2023 | $6.50 – $7.00 | New |
| Jul 27, 2023 | operating cash flow | FY2023 | $1.40B | Reaffirmed |
| Apr 27, 2023 | adjusted 2023 EPS | FY2023 | +5% – +15% | Reaffirmed |
| Apr 27, 2023 | operating cash flow | FY2023 | $1.40B | Reaffirmed |
| Jan 26, 2023 | adjusted 2023 EPS | FY2023 | +5% – +15% | New |
| Jan 26, 2023 | operating cash flow | FY2023 | $1.40B | New |
| Oct 27, 2022 | adjusted EPS | Q4 FY2022 | $1.10 – $1.40 | New |
| Oct 27, 2022 | adjusted EPS | FY2022 | $8.05 – $8.35 | Lowered |
| Oct 27, 2022 | operating cash flow | FY2022 | $1.00B – $1.20B | Lowered |
| Jul 28, 2022 | adjusted EPS | FY2022 | $9.50 – $10.00 | Reaffirmed |
| Jul 28, 2022 | operating cash flow | FY2022 | $1.50B | Lowered |
| Apr 28, 2022 | adjusted EPS growth | Q2 FY2022 | +8% – +12% | New |
| Apr 28, 2022 | adjusted EPS | FY2022 | $9.50 – $10.00 | Reaffirmed |
| Apr 28, 2022 | operating cash flow | FY2022 | $1.60B | New |
| Jan 27, 2022 | adjusted EPS growth | FY2022 | +8% – +12% | New |
| Jan 27, 2022 | adjusted EPS | FY2022 | $9.50 – $10.00 | New |
| Oct 28, 2021 | adjusted EPS | FY2021 | $8.80 – $9.00 | New |
| Oct 28, 2021 | free cash flow | FY2021 | $1.10B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Eastman Chemical filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
- Update
- Results
- Results
- Update
- Results
- News
- News
- News
- News
See a number that looks wrong?